Page last updated: 2024-10-30

leflunomide and Bone Neoplasms

leflunomide has been researched along with Bone Neoplasms in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.

Research Excerpts

ExcerptRelevanceReference
"Treatment with leflunomide, a potent activator of mitochondrial fusion proteins, overcame inhibitory effects of fission on migration, signaling, and metastasis."1.56Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer. ( Bevoor, A; Boppisetti, J; Buschhaus, JM; Chen, YC; Chiang, B; Cutter, AC; Eckley, S; Ghosh, P; Haley, HR; Humphries, BA; Lahann, J; Luker, GD; Luker, KE; Neale, DB; Palagama, DSW; Qyli, T; Robison, TH; Ross, BD; Sahoo, D; Sahoo, S; Spinosa, PC; Yoon, E, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Humphries, BA1
Cutter, AC1
Buschhaus, JM1
Chen, YC1
Qyli, T1
Palagama, DSW1
Eckley, S1
Robison, TH1
Bevoor, A1
Chiang, B1
Haley, HR1
Sahoo, S1
Spinosa, PC1
Neale, DB1
Boppisetti, J1
Sahoo, D1
Ghosh, P1
Lahann, J1
Ross, BD1
Yoon, E1
Luker, KE1
Luker, GD1

Other Studies

1 other study available for leflunomide and Bone Neoplasms

ArticleYear
Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.
    Breast cancer research : BCR, 2020, 06-05, Volume: 22, Issue:1

    Topics: Animals; Bone Neoplasms; Carboxy-Lyases; Cell Transformation, Neoplastic; Female; Humans; Immunosupp

2020